Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

Cell Death and Differentiation

Volumn 23, Issue 1, 2016, Pages 76-88

  Rodriguez, D A ^a   Weinlich, R ^a,d   Brown, S ^a   Guy, C ^a   Fitzgerald, P ^a   Dillon, C P ^a   Oberst, A ^b   Quarato, G ^a   Low, J ^a   Cripps, J G ^c   Chen, T ^a   Green, D R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE DOMAIN LIKE PSEUDOKINASE; MONOCLONAL ANTIBODY; OLIGOMER; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE KINASE 3; SERINE; THREONINE; UNCLASSIFIED DRUG; AMINO ACID; MLKL PROTEIN, MOUSE; MULTIPROTEIN COMPLEX; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, MOUSE; RIPK3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; GENETICS; METABOLISM; MOUSE; NECROSIS; PHOSPHORYLATION;

AMINO ACIDS; ANIMALS; CELL DEATH; CELL MEMBRANE; MICE; MULTIPROTEIN COMPLEXES; NECROSIS; PHOSPHORYLATION; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84949537573     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.70     Document Type: Article

References (40)

1. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J., et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012; 109: 5322-5327.
2. Sun L, Wang H, Wang Z, He S, Chen S, Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213-227.
3. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-453.
4. Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012; 150: 339-350.
5. Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS. RIPK-Dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 2011; 44: 9-16.
6. Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, Lukens JR., et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep 2013; 5: 340-348.
7. Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T., et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012; 1: 401-407.
8. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-Dependent necrosis. Nature 2011; 471: 363-367.
9. Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R., et al. RIP3 mediates the embryonic lethality of caspase-8-Deficient mice. Nature 2011; 471: 368-372.
10. Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011; 471: 373-376.
11. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P., et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 2014; 157: 1189-1202.
12. Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C., et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 2014; 111: 7753-7758.
13. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T., et al. RIPK1 regulates RIPK3-MLKL-Driven systemic inflammation and emergency hematopoiesis. Cell 2014; 157: 1175-1188.
14. Weinlich R, Green DR. The two faces of receptor interacting protein kinase-1. Mol Cell 2014; 56: 469-480.
15. Chen X, Li W, Ren J, Huang D, HeWT, Song Y., et al. Translocation ofmixed lineage kinase domainlike protein to plasma membrane leads to necrotic cell death. Cell Res 2014; 24: 105-121.
16. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF., et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014; 54: 133-146.
17. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J., et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014; 16: 55-65.
18. Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P., et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci USA 2014; 111: 15072-15077.
19. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014; 7: 971-981.
20. Xie T, Peng W, Yan C, Wu J, Gong X, Shi Y. Structural insights into RIP3-mediated necroptotic signaling. Cell Rep 2013; 5: 70-78.
21. Green DR. Pseudokiller, qu'est-ce que c'est?. Immunity 2013; 39: 421-422.
22. Weinert BT, Scholz C, Wagner SA, Iesmantavicius V, Su D, Daniel JA., et al. Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep 2013; 4: 842-851.
23. Verdin E, Ott M. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol 2014; 16: 258-264.
24. Orozco S, Yatim N, Werner MR, Tran H, Gunja SY, Tait SW., et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 2014; 21: 1511-1521.
25. Tait SW, Oberst A, Quarato G, Milasta S, Haller M, Wang R., et al. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep 2013; 5: 878-885.
26. Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M., et al. Interferon-induced RIP1/ RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci USA 2013; 110: E3109-E3118.
27. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ., et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 2013; 288: 31268-31279.
28. Li JX, Feng JM, Wang Y, Li XH, Chen XX, Su Y., et al. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 2014; 5: e1278.
29. Wu XN, Yang ZH, Wang XK, Zhang Y, Wan H, Song Y., et al. Distinct roles of RIP1-RIP3 hetero-And RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ 2014; 21: 1709-1720.
30. Chen W, Zhou Z, Li L, Zhong CQ, Zheng X, Wu X., et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem 2013; 288: 16247-16261.
31. Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, Dejardin E., et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-Dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 2013; 20: 1381-1392.
32. Tenev T, Bianchi K, Darding M, Broemer M, Langlais C,Wallberg F., et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011; 43: 432-448.
33. Remijsen Q, Goossens V, Grootjans S, Van den Haute C, Vanlangenakker N, Dondelinger Y., et al. Depletion of RIPK3 or MLKL blocks TNF-Driven necroptosis and switches towards a delayed RIPK1 kinase-Dependent apoptosis. Cell Death Dis 2014; 5: e1004.
34. Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H., et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 2014; 56: 481-495.
35. Cook WD, Moujalled DM, Ralph TJ, Lock P, Young SN, Murphy JM., et al. RIPK1-And RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 2014; 21: 1600-1612.
36. Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013; 57: 1773-1783.
37. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007; 56: 181-200.
38. Kyung Kim S, Kim WJ, Yoon JH, Ji JH, Morgan MJ, Cho H., et al. Upregulated RIP3 expression potentiates MLKL phosphorylation-mediated programmed necrosis in toxic epidermal necrolysis. J Invest Dermatol 2015; 135: 2021-2030.
39. Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD., et al. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat Med 2014; 20: 204-208.
40. Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P., et al. Microtubuleassociated protein 1 light chain 3 alpha (LC3)-Associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci USA 2011; 108: 17396-17401.